Canute Scott A Insider Trades

Insider Trading History

Track insider trading activity for Canute Scott A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Oncorus
Oncorus ONCR
Director
Holding Value $1.58k 12,500 shares
Last Trade
Jun 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40k 25,000 shares
$1.60
$0.13
Flexion Therapeutics
Flexion Therapeutics FLXN
Director
Holding Value $0 0 shares
Last Trade
Nov 19, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$912k 100,000 shares
$9.12
$25.05
Flexion Therapeutics
Flexion Therapeutics FLXN
Director
Holding Value $225k 9,000 shares
Last Trade
Jun 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 11,500 shares
$9.22
$25.05
Oncorus
Oncorus ONCR
Director
Holding Value $1.58k 12,500 shares
Last Trade
Jun 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$207k 12,500 shares
$16.55
$0.13
Oncorus
Oncorus ONCR
Director
Holding Value $3.15k 25,000 shares
Last Trade
Dec 11, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$650k 25,000 shares
$26.00
$0.13
Flexion Therapeutics
Flexion Therapeutics FLXN
Director
Holding Value $175k 7,000 shares
Last Trade
Jun 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83.2k 7,000 shares
$11.88
$25.05
Flexion Therapeutics
Flexion Therapeutics FLXN
Director
Holding Value $313k 12,500 shares
Last Trade
Jun 19, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$147k 12,500 shares
$11.74
$25.05
Akebia Therapeutics
Akebia Therapeutics AKBA
Director
Holding Value $22.1k 20,100 shares
Last Trade
Jun 06, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 33,800 shares
$4.23
$1.10
Flexion Therapeutics
Flexion Therapeutics FLXN
Director
Holding Value $313k 12,500 shares
Last Trade
Jun 20, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$352k 12,500 shares
$28.14
$25.05
Akebia Therapeutics
Akebia Therapeutics AKBA
Director
Holding Value $13.8k 12,500 shares
Last Trade
Jun 14, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$139k 12,500 shares
$11.14
$1.10
Protara Therapeutics
Protara Therapeutics TARA
Director
Holding Value $50.8k 12,700 shares
Last Trade
Jun 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 12,700 shares
$100.00
$4.00
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $25.5k 15,000 shares
Last Trade
Oct 26, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.8k 15,000 shares
$1.32
$1.70
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $450 15,000 shares
Last Trade
Oct 26, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23k 15,000 shares
$0.08
$0.03
Flexion Therapeutics
Flexion Therapeutics FLXN
Director
Holding Value $313k 12,500 shares
Last Trade
Jun 22, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$252k 12,500 shares
$20.16
$25.05
Protara Therapeutics
Protara Therapeutics TARA
Director
Holding Value $26.7k 6,666 shares
Last Trade
Jun 20, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$347k 6,666 shares
$52.00
$4.00
Akebia Therapeutics
Akebia Therapeutics AKBA
Director
Holding Value $13.8k 12,500 shares
Last Trade
Jun 15, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$359k 25,000 shares
$14.37
$1.10
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $137k 80,500 shares
Last Trade
Dec 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$202k 80,500 shares
$2.51
$1.70
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $2.42k 80,500 shares
Last Trade
Dec 22, 2016 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$6.11k 80,500 shares
$0.08
$0.03
Outlook Therapeutics
Outlook Therapeutics OTLK
Director
Holding Value $419k 246,342 shares
Last Trade
Nov 28, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$351k 94,723 shares
$3.71
$1.70
Outlook Therapeutics- Warrants
Outlook Therapeutics- Warrants OTLKW
Director
Holding Value $7.39k 246,342 shares
Last Trade
Nov 28, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$36.9k 94,723 shares
$0.39
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up